Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|August 23, 2014
Immunotherapy in pediatric malignancies: current status and future perspectivesChristian M Capitini, Mario Otto, Kenneth B DeSantes, et al.
Pediatric Diabetes|August 31, 2016
Curative potential of allogeneic hematopoietic stem cell transplant in type 1 diabetesKristen E McCabe, Allison J Pollock, Jennifer L Rehm, et al.
Journal of Pediatric Hematology/Oncology|June 7, 2007
Successful treatment of an infant with constitutional chromosomal abnormality and hemangiopericytoma with chemotherapy aloneL Kate Gowans, Michael L Bentz, Kenneth B DeSantes, et al.
Pediatric Blood & Cancer|October 29, 2010
KIR receptor-ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cellsDavid Delgado, Daniel E Webster, Kenneth B DeSantes, et al.
Journal of Pediatric Hematology/Oncology|January 16, 2015
NK cell-based immunotherapies in Pediatric OncologyKimberly A McDowell, Jacquelyn A Hank, Kenneth B DeSantes, et al.
Journal of Pediatric Hematology/Oncology|December 4, 2021
Undifferentiated and Unresectable Sarcoma With NTRK3-Fusion in a Pediatric Patient Treated With Larotrectinib and Proton Beam RadiotherapyMallery R Olsen, Ryan A Denu, Jane B Lyon, et al.
Integrative Cancer Science and Therapeutics|December 14, 2019
Reduction in oral mucositis severity using a topical vasoconstrictor: A case report of three bone marrow transplant patientsAmanda Graul-Conroy, Margo Hoover-Regan, Kenneth B DeSantes, et al.
Cancer Research Communications|August 12, 2025
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid TumorsKenneth B DeSantes, Kimberly A McDowell, Paul M Sondel, et al.
Cytotherapy|June 16, 2020
Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservationSudarshawn N Damodharan, Kirsti L Walker, Matthew H Forsberg, et al.
Pageof 2